These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 22982021)

  • 1. Sphingolipid signaling in metabolic disorders.
    Hla T; Dannenberg AJ
    Cell Metab; 2012 Oct; 16(4):420-34. PubMed ID: 22982021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 and regulation of bioactive sphingolipids.
    Heffernan-Stroud LA; Obeid LM
    Adv Enzyme Regul; 2011; 51(1):219-28. PubMed ID: 21035490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingolipids and Lipoproteins in Health and Metabolic Disorders.
    Iqbal J; Walsh MT; Hammad SM; Hussain MM
    Trends Endocrinol Metab; 2017 Jul; 28(7):506-518. PubMed ID: 28462811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options.
    Kacher Y; Futerman AH
    FEBS Lett; 2006 Oct; 580(23):5510-7. PubMed ID: 16970941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingolipids in metabolic disease: The good, the bad, and the unknown.
    Green CD; Maceyka M; Cowart LA; Spiegel S
    Cell Metab; 2021 Jul; 33(7):1293-1306. PubMed ID: 34233172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.
    Holland WL; Summers SA
    Endocr Rev; 2008 Jun; 29(4):381-402. PubMed ID: 18451260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential therapeutic targets for atherosclerosis in sphingolipid metabolism.
    Yu Z; Peng Q; Huang Y
    Clin Sci (Lond); 2019 Mar; 133(6):763-776. PubMed ID: 30890654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medicinal chemistry aspects of drug targets in sphingolipid metabolism.
    Nussbaumer P
    ChemMedChem; 2008 Apr; 3(4):543-51. PubMed ID: 18061920
    [No Abstract]   [Full Text] [Related]  

  • 9. Sphingolipid metabolism and neutral sphingomyelinases.
    Airola MV; Hannun YA
    Handb Exp Pharmacol; 2013; (215):57-76. PubMed ID: 23579449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
    Sakamoto W; Canals D; Salamone S; Allopenna J; Clarke CJ; Snider J; Obeid LM; Hannun YA
    J Lipid Res; 2019 Nov; 60(11):1841-1850. PubMed ID: 31243119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary and Endogenous Sphingolipid Metabolism in Chronic Inflammation.
    Norris GH; Blesso CN
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29143791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Mechanisms of Sphingolipid Transport on Plasma Lipoproteins.
    Iqbal J; Al Qarni A; Bakillah A
    Adv Exp Med Biol; 2022; 1372():57-65. PubMed ID: 35503174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipid homeostasis in the web of metabolic routes.
    Aguilera-Romero A; Gehin C; Riezman H
    Biochim Biophys Acta; 2014 May; 1841(5):647-56. PubMed ID: 24184514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingolipids in obesity, type 2 diabetes, and metabolic disease.
    Russo SB; Ross JS; Cowart LA
    Handb Exp Pharmacol; 2013; (216):373-401. PubMed ID: 23563667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic probes and chemical tools in sphingolipid research.
    Chen J; Devaraj NK
    Curr Opin Chem Biol; 2021 Dec; 65():126-135. PubMed ID: 34509716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular facets of sphingolipids: mediators of diseases.
    Ozbayraktar FB; Ulgen KO
    Biotechnol J; 2009 Jul; 4(7):1028-41. PubMed ID: 19579220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingolipid-binding proteins.
    Snook CF; Jones JA; Hannun YA
    Biochim Biophys Acta; 2006 Aug; 1761(8):927-46. PubMed ID: 16901751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingolipids and their metabolism in physiology and disease.
    Hannun YA; Obeid LM
    Nat Rev Mol Cell Biol; 2018 Mar; 19(3):175-191. PubMed ID: 29165427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pleiotropic roles of sphingolipid signaling in autophagy.
    Li Y; Li S; Qin X; Hou W; Dong H; Yao L; Xiong L
    Cell Death Dis; 2014 May; 5(5):e1245. PubMed ID: 24853423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.
    Meikle PJ; Summers SA
    Nat Rev Endocrinol; 2017 Feb; 13(2):79-91. PubMed ID: 27767036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.